| Primary |
| Mydriasis |
50.0% |
| Drug Use For Unknown Indication |
16.7% |
| General Anaesthesia |
16.7% |
| Product Used For Unknown Indication |
16.7% |
|
| Drug Dependence |
25.0% |
| Eye Irritation |
25.0% |
| Heart Sounds Abnormal |
25.0% |
| Infantile Apnoeic Attack |
25.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
28.0% |
| Product Used For Unknown Indication |
13.3% |
| Induction Of Anaesthesia |
10.7% |
| Tocolysis |
10.7% |
| Infection Prophylaxis |
5.3% |
| Premedication |
5.3% |
| Anaesthesia |
2.7% |
| Analgesic Therapy |
2.7% |
| Aortic Valve Disease |
2.7% |
| Coronary Artery Bypass |
2.7% |
| Diabetes Mellitus |
2.7% |
| General Anaesthesia |
2.7% |
| Hypotension |
2.7% |
| Maintenance Of Anaesthesia |
2.7% |
| Mydriasis |
2.7% |
| Choroidal Neovascularisation |
1.3% |
| Macular Degeneration |
1.3% |
|
| Intra-uterine Death |
16.7% |
| Nephrogenic Diabetes Insipidus |
16.7% |
| Tachycardia |
16.7% |
| Anhedonia |
8.3% |
| Erythema Multiforme |
8.3% |
| Fear |
8.3% |
| Hypercapnia |
8.3% |
| Oxygen Saturation Immeasurable |
8.3% |
| Ventricular Tachycardia |
8.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
61.2% |
| Drug Use For Unknown Indication |
21.5% |
| Coronary Artery Bypass |
4.8% |
| Mitral Valve Replacement |
1.9% |
| Aortic Valve Replacement |
1.8% |
| Intra-aortic Balloon Placement |
1.5% |
| Preoperative Care |
0.8% |
| Hypertension |
0.7% |
| Deep Vein Thrombosis |
0.6% |
| Atrial Fibrillation |
0.6% |
| Cardiac Operation |
0.6% |
| Cardiopulmonary Bypass |
0.6% |
| Catheterisation Cardiac |
0.5% |
| Pain |
0.5% |
| Anticoagulant Therapy |
0.4% |
| Anxiety |
0.4% |
| Diabetes Mellitus |
0.4% |
| Chronic Obstructive Pulmonary Disease |
0.4% |
| Aortic Dissection |
0.3% |
| Blood Pressure Management |
0.3% |
|
| Pain |
14.1% |
| Anhedonia |
12.8% |
| Injury |
11.5% |
| Unevaluable Event |
8.3% |
| Vomiting |
6.4% |
| Emotional Distress |
5.8% |
| Renal Failure |
5.8% |
| Anxiety |
5.1% |
| Fear |
4.5% |
| Depression |
3.2% |
| Renal Impairment |
3.2% |
| Renal Injury |
2.6% |
| Urinary Tract Infection |
2.6% |
| Weight Increased |
2.6% |
| Corneal Oedema |
1.9% |
| Death |
1.9% |
| Multi-organ Failure |
1.9% |
| Renal Failure Acute |
1.9% |
| Respiratory Failure |
1.9% |
| Septic Shock |
1.9% |
|
